Stealth Rally Continues Despite Weak Economic Forecasts: Life Science Stocks Up Over 2.5%
Personalized Medicine Achieves Milestone with Lung Cancer Drug Friday's rally picked up steam today as devastation from Hurricane Irene was less than expected and consumer spending was up. Greek stocks also rallied on a bank merger. Why are Greek stocks boosting this market? NASDAQ and the...
Stocks Rally as Fed Shifts to Idle: Biotechs Strong ILMN, SGEN
Can Congress Ignore a 78% Disapproval Rating? All the anticipation of the FED and Jackson Hole went to the ZEN mode-do nothing and the market will rally. Investors apparently were interpreting this as the economy isn't bad enough to warrant stimulus. Around 10:25am today NASDAQ went into an...
Risk Off: Day Traders and Robots Rule
A day before the Bernanke addresses the public on potential FED plans and the state of the economy the market reverted back to the Euro Debt crisis selling tracking the European stocks decline. The market major indices sold off 1.5% while the FTSE-100 was off 1.44%. NASDAQ was off 1.95%. The...
Three Days of Market Gains: Biotechnology Trades Are Holding
Drug Stocks with Dividends for Safety and Appreciation On Monday AM we thought blue chip drug and biotech stocks were poised to rally and we were rewarded. The S&P has come back to early August depressed levels but we have a double bottom in August. Healthcare overall was up 0.53% today...
Global Recession Fears Dominate Market: Safety in Biotechnology and Large Cap Drug Stocks
Got Gold and U.S. Treasuries? It is impossible to really describe the market turmoil in the space below so let this post from Investor Uprising suffice. With 10 Year treasuries under 2% and Gold approaching $1900 fear is pervasive. Bankers meet in Jackson Hole next week and we will hear more...